Coverage

The Floridian: Congress Should Press for FDA Reform to Crack Down on Illegal E-Cigarettes
According to findings by the Reagan Udall Foundation, that is exactly what is happening as stakeholders navigating the process “expressed concerns about a lack of clarity, transparency, and communication” regarding the CTP’s priorities and decision-…
Read More
Government Executive: How the FDA could shape the future of psychedelics research
FDA draft guidance posted in June 2023 provides a potential framework on how to overcome expectancy bias and the nocebo effect by employing an active placebo which could be a substance that also has mind-altering effects but no expected therapeutic…
Read More
Vapor Voice: FDA Posts 2 Regulatory Science Memos for Vapes
In April, FDA resumed the posting of regulatory science policy memos, with a subsequent release in May. The release of these latest memos reflects the CTP’s ongoing commitment to enhance transparency consistent with the December 2022 evaluation of the…
Read More
Food Safety News: FDA's new Human Foods Program is recruiting its start-up talent to help Jim Jones
In January 2023, the FDA announced it would develop a reorganization proposal to create a unified Human Foods Program and restructure its field operations (Office of Regulatory Affairs) after carefully reviewing the findings and recommendations of an…
Read More
Produce Grower: FDA's new food boss
Jones spent 30 years working at the U.S. Environmental Protection Agency, primarily as a pesticide regulator, and served on the Reagan-Udall Foundation’s Independent Expert Panel for Foods, which submitted a report on the operational evaluation of the…
Read More
Exponent: Accelerating Breakthroughs for FDA-Regulated Products
The paper, titled "In Silico Technologies: A Strategic Imperative for Accelerating Breakthroughs and Market Leadership for FDA-Regulated Products," has been published online by Regulatory Science Accelerator (RSA), a platform developed by the Reagan-…
Read More
Food Safety Magazine: Another Evaluation of Infant Formula Crisis Concludes FDA Needs More Authorities to Prevent Shortages
Among other recommendations, the NSAEM report reiterates other sentiments expressed by FDA and the Reagan-Udall Foundation, as well as consumer advocacy groups; specifically, that FDA’s authority to oversee manufacturing significantly hindered the…
Read More
FDA: Actions to Address Recommendations from the Reagan-Udall Evaluation of CTP
In September 2022, per the request of the FDA Commissioner, Dr. Robert Califf, an independent expert panel facilitated by the Reagan-Udall Foundation began an operational evaluation of the agency’s Center for Tobacco Products (CTP). Read more
Read More
The Potential of Ketamine: Public Workshop and New Research Explores Uses
In collaboration with the US Food and Drug Administration (FDA), the Reagan-Udall Foundation for the FDA, is today hosting a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest." Read more
Read More
FDA: Medical Countermeasures Initiative (MCMi) Program Update
This annual report provides an update on FDA's work to support medical countermeasure-related public health preparedness and response efforts. Read more
Read More